We are live on ! Find out more
ATRC icon

AtriCure

224 hedge funds and large institutions have $1.46B invested in AtriCure in 2026 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 82 increasing their positions, 66 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

96% more call options, than puts

Call options by funds: $280K | Put options by funds: $143K

24% more repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 66

2.43% more ownership

Funds ownership: 97.99%100.42% (+2.4%)

4% less funds holding

Funds holding: 233224 (-9)

12% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 41

24% less capital invested

Capital invested by funds: $1.93B → $1.46B (-$465M)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
224
Holders Change
-9
Holders Change %
-3.86%
% of All Funds
2.74%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.02%
New
36
Increased
82
Reduced
66
Closed
41
Calls
$280K
Puts
$143K
Net Calls
+$137K
Net Calls Change
-$402K

ATRC Hedge Fund Activity: Q1 2026 in Review

224 of the 8,187 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q1 2026, worth a combined $1.46B — down 24% from $1.93B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of ATRC and 36 opened new positions — a net loss of 5 holders — while 66 trimmed existing stakes and 82 added.

The largest buyer was Divisadero Street Capital Management, opening a new position worth an estimated $39.6M. The largest seller was Wellington Management Group, cutting an estimated $18.3M.

  • 224 institutional investors held AtriCure (ATRC) as of Q1 2026, down from 233 in Q4 2025.
  • Funds reported $1.46B of AtriCure stock for Q1 2026, down 24% quarter-over-quarter.
  • 36 funds opened new AtriCure positions in Q1 2026 and 41 closed out, a net change of -5 holders.
  • The largest AtriCure buyer in Q1 2026 was Divisadero Street Capital Management, an estimated $39.6M added.
  • The largest AtriCure seller in Q1 2026 was Wellington Management Group, an estimated $18.3M sold.

Based on aggregated 13F filings for Q1 2026.